During the past decade, Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia" are "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia" in a lesser frequency.

Most popular intervention types in "Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (2 trials), "paclitaxel" (2 trials) and "liposomal doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".